4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-009716
Chief Development Officer sold 238 shares at $11.32 ($2,694)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Development Officer | 2023-03-20 | Sale | −238 | $11.32 | $2,694 | 91,293 | D: show line 1 in the form |
| Open-market sales · 238 sh · avg $11.32 · $2,694 | |||||||
Loading xslF345X04/doc4.xml…